AMGN
Price
$290.33
Change
+$3.23 (+1.13%)
Updated
Jun 6 closing price
Capitalization
151.69B
57 days until earnings call
MRK
Price
$78.97
Change
+$1.35 (+1.74%)
Updated
Jun 6 closing price
Capitalization
331.75B
50 days until earnings call
Interact to see
Advertisement

AMGN vs MRK

Header iconAMGN vs MRK Comparison
Open Charts AMGN vs MRKBanner chart's image
Amgen
Price$290.33
Change+$3.23 (+1.13%)
Volume$2M
Capitalization151.69B
Merck & Co
Price$78.97
Change+$1.35 (+1.74%)
Volume$9.86M
Capitalization331.75B
AMGN vs MRK Comparison Chart
Loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGN vs. MRK commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and MRK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (AMGN: $278.40 vs. MRK: $76.17)
Brand notoriety: AMGN and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 128% vs. MRK: 78%
Market capitalization -- AMGN: $151.69B vs. MRK: $331.75B
AMGN [@Pharmaceuticals: Major] is valued at $151.69B. MRK’s [@Pharmaceuticals: Major] market capitalization is $331.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 2 FA rating(s) are green whileMRK’s FA Score has 2 green FA rating(s).

  • AMGN’s FA Score: 2 green, 3 red.
  • MRK’s FA Score: 2 green, 3 red.
According to our system of comparison, AMGN is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 4 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).

  • AMGN’s TA Score: 4 bullish, 4 bearish.
  • MRK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MRK is a better buy in the short-term than AMGN.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +2.60% price change this week, while MRK (@Pharmaceuticals: Major) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.22%. For the same industry, the average monthly price growth was +3.78%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

AMGN is expected to report earnings on Aug 05, 2025.

MRK is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.22% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than AMGN($152B). MRK has higher P/E ratio than AMGN: MRK (935.64) vs AMGN (22.66). AMGN YTD gains are higher at: 8.628 vs. MRK (-22.770). AMGN has higher annual earnings (EBITDA): 14.8B vs. MRK (6.91B). AMGN has more cash in the bank: 10.9B vs. MRK (7.09B). MRK has less debt than AMGN: MRK (35.1B) vs AMGN (64.6B). MRK has higher revenues than AMGN: MRK (60.1B) vs AMGN (28.2B).
AMGNMRKAMGN / MRK
Capitalization152B332B46%
EBITDA14.8B6.91B214%
Gain YTD8.628-22.770-38%
P/E Ratio22.66935.642%
Revenue28.2B60.1B47%
Total Cash10.9B7.09B154%
Total Debt64.6B35.1B184%
FUNDAMENTALS RATINGS
AMGN vs MRK: Fundamental Ratings
AMGN
MRK
OUTLOOK RATING
1..100
568
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
3677
SMR RATING
1..100
1624
PRICE GROWTH RATING
1..100
5864
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (9) in the Pharmaceuticals Major industry is in the same range as AMGN (19) in the Biotechnology industry. This means that MRK’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's Profit vs Risk Rating (36) in the Biotechnology industry is somewhat better than the same rating for MRK (77) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew somewhat faster than MRK’s over the last 12 months.

AMGN's SMR Rating (16) in the Biotechnology industry is in the same range as MRK (24) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to MRK’s over the last 12 months.

AMGN's Price Growth Rating (58) in the Biotechnology industry is in the same range as MRK (64) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to MRK’s over the last 12 months.

AMGN's P/E Growth Rating (91) in the Biotechnology industry is in the same range as MRK (100) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNMRK
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
41%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
53%
Bullish Trend 12 days ago
55%
Momentum
ODDS (%)
Bullish Trend 12 days ago
61%
Bearish Trend 12 days ago
51%
MACD
ODDS (%)
Bullish Trend 12 days ago
53%
Bullish Trend 12 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
59%
Bearish Trend 12 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
54%
Bearish Trend 12 days ago
45%
Advances
ODDS (%)
Bullish Trend 21 days ago
56%
Bullish Trend 13 days ago
48%
Declines
ODDS (%)
Bearish Trend 19 days ago
52%
Bearish Trend 26 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
61%
Bullish Trend 12 days ago
54%
Aroon
ODDS (%)
Bearish Trend 12 days ago
51%
Bearish Trend 12 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-0.38%
PFE - AMGN
57%
Loosely correlated
-1.82%
NVS - AMGN
52%
Loosely correlated
-1.18%
BIIB - AMGN
51%
Loosely correlated
-0.67%
ABBV - AMGN
49%
Loosely correlated
-1.42%
GSK - AMGN
49%
Loosely correlated
-0.66%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-1.83%
PFE - MRK
46%
Loosely correlated
-1.82%
BIIB - MRK
41%
Loosely correlated
-0.67%
AMGN - MRK
41%
Loosely correlated
-0.38%
ABBV - MRK
41%
Loosely correlated
-1.42%
AZN - MRK
40%
Loosely correlated
-0.82%
More